These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22352988)

  • 1. Temporal pattern and costs of rehospitalization in atrial fibrillation/atrial flutter patients with one or more additional risk factors.
    Amin AN; Jhaveri M; Lin J
    J Med Econ; 2012; 15(3):548-55. PubMed ID: 22352988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital readmissions in US atrial fibrillation patients: occurrence and costs.
    Amin AN; Jhaveri M; Lin J
    Am J Ther; 2013; 20(2):143-50. PubMed ID: 23183097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
    Amin AN; Jhaveri M; Lin J
    Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
    Naccarelli GV; Panaccio MP; Cummins G; Tu N
    Am J Cardiol; 2012 May; 109(10):1526-33. PubMed ID: 22360819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.
    Naccarelli GV; Johnston SS; Lin J; Patel PP; Schulman KL
    Clin Cardiol; 2010 May; 33(5):270-9. PubMed ID: 20513065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
    Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
    Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.
    Dasari TW; Pavlovic-Surjancev B; Patel N; Williams AA; Ezidinma P; Rupani A; Sinacore JL; Heroux AL
    Am J Cardiol; 2010 Sep; 106(5):737-41. PubMed ID: 20723655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter.
    Kim MH; Lin J; Jhaveri M; Koren A
    Adv Ther; 2014 Mar; 31(3):318-32. PubMed ID: 24595638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter.
    Naccarelli GV; Johnston SS; Dalal M; Lin J; Patel PP
    Am J Cardiol; 2012 Feb; 109(4):543-9. PubMed ID: 22118826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of isolated atrial flutter versus atrial flutter combined with atrial fibrillation.
    Peyrol M; Sbragia P; Bonello L; Lévy S; Paganelli F
    Arch Cardiovasc Dis; 2011 Oct; 104(10):530-5. PubMed ID: 22044706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Readmissions and repeat procedures after catheter ablation for atrial fibrillation.
    Opolski G; Januszkiewicz Ł; Szczerba E; Osińska B; Rutkowski D; Kalarus Z; Kaźmierczak J
    Cardiol J; 2015; 22(6):630-6. PubMed ID: 26100826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
    De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
    G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of atrial fibrillation ablation during mitral surgery in patients with poor electro-anatomical substrate.
    Onorati F; Rubino AS; Mariscalco G; Serraino F; Sala A; Renzulli A
    J Heart Valve Dis; 2009 Nov; 18(6):607-16. PubMed ID: 20099709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of atrial fibrillation in United States managed care organizations.
    Kim MH; Lin J; Hussein M; Kreilick C; Battleman D
    Adv Ther; 2009 Sep; 26(9):847-57. PubMed ID: 19768638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher rate of recurrent atrial flutter and atrial fibrillation following atrial flutter ablation after cardiac surgery.
    Aktas MK; Khan MN; Di Biase L; Elayi C; Martin D; Saliba W; Cummings J; Schweikert R; Natale A
    J Cardiovasc Electrophysiol; 2010 Jul; 21(7):760-5. PubMed ID: 20132385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of potential cost savings associated with reduced rates of cardiovascular hospitalization among atrial fibrillation/flutter patients treated with dronedarone in the ATHENA trial.
    Reynolds MR; Lin J; Jhaveri M; Mozaffari E; Plich A
    Am J Ther; 2014; 21(6):500-8. PubMed ID: 23344106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing prevalence of atrial fibrillation and flutter in the United States.
    Naccarelli GV; Varker H; Lin J; Schulman KL
    Am J Cardiol; 2009 Dec; 104(11):1534-9. PubMed ID: 19932788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
    Vamos M; Calkins H; Kowey PR; Torp-Pedersen CT; Corp Dit Genti V; Wieloch M; Koren A; Hohnloser SH
    Clin Cardiol; 2020 Mar; 43(3):291-297. PubMed ID: 31872901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.